Applications of Platelet-Rich Plasma in Lymphedema.
Identifieur interne : 000636 ( PubMed/Corpus ); précédent : 000635; suivant : 000637Applications of Platelet-Rich Plasma in Lymphedema.
Auteurs : Ahmet Akgül ; Musa Cirak ; Tansu BirinciSource :
- Lymphatic research and biology [ 1557-8585 ] ; 2016.
Abstract
Platelet-rich plasma (PRP) is an autologous concentrated preparation of human platelets contained in a small volume of plasma that is characterized by hemostatic and tissue-repairing effects. Being enriched by various kinds of growth factors, and their tissue-repairing effects have made them the focus of attention for use in tissue regeneration. PRP has been safely used and documented in many different fields, including orthopedics, sports injuries, dental and periodontal surgery, and cosmetic, plastic, cardiovascular, general, and maxillofacial surgery. The current evidence obtained from in vitro and animal studies pointed out that PRP may potentially be used to regenerate injured lymphatic vessels to treat or prevent lymphedema. Therefore, we have reviewed existing literature on the clinical uses of PRP in lymphedema and inquired whether there is enough evidence to support the use of PRP in clinical practice as a treatment option. In contrast to in vitro and animal models, there is no clinical trial regarding the use of PRP in lymphedema treatment. Only two animal studies matched to our research yielded positive and promising results in terms of the potential role of PRP in future for lymphedema therapies. In the light of these findings, it is clear that this is an important issue that should be studied in greater depth to clarify the efficacy of PRP in the management of lymphedema.
DOI: 10.1089/lrb.2015.0060
PubMed: 27599222
Links to Exploration step
pubmed:27599222Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Applications of Platelet-Rich Plasma in Lymphedema.</title><author><name sortKey="Akgul, Ahmet" sort="Akgul, Ahmet" uniqKey="Akgul A" first="Ahmet" last="Akgül">Ahmet Akgül</name><affiliation><nlm:affiliation>1 Department of Gerontology, Faculty of Health Sciences, Istanbul University , Istanbul, Turkey .</nlm:affiliation></affiliation></author><author><name sortKey="Cirak, Musa" sort="Cirak, Musa" uniqKey="Cirak M" first="Musa" last="Cirak">Musa Cirak</name><affiliation><nlm:affiliation>3 Department of Neurosurgery, Bakırköy Dr. Sadi Konuk Training and Research Hospital , Istanbul, Turkey .</nlm:affiliation></affiliation></author><author><name sortKey="Birinci, Tansu" sort="Birinci, Tansu" uniqKey="Birinci T" first="Tansu" last="Birinci">Tansu Birinci</name><affiliation><nlm:affiliation>4 Department of Physiotherapy and Rehabilitation, Istanbul University , Istanbul, Turkey .</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27599222</idno><idno type="pmid">27599222</idno><idno type="doi">10.1089/lrb.2015.0060</idno><idno type="wicri:Area/PubMed/Corpus">000636</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000636</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Applications of Platelet-Rich Plasma in Lymphedema.</title><author><name sortKey="Akgul, Ahmet" sort="Akgul, Ahmet" uniqKey="Akgul A" first="Ahmet" last="Akgül">Ahmet Akgül</name><affiliation><nlm:affiliation>1 Department of Gerontology, Faculty of Health Sciences, Istanbul University , Istanbul, Turkey .</nlm:affiliation></affiliation></author><author><name sortKey="Cirak, Musa" sort="Cirak, Musa" uniqKey="Cirak M" first="Musa" last="Cirak">Musa Cirak</name><affiliation><nlm:affiliation>3 Department of Neurosurgery, Bakırköy Dr. Sadi Konuk Training and Research Hospital , Istanbul, Turkey .</nlm:affiliation></affiliation></author><author><name sortKey="Birinci, Tansu" sort="Birinci, Tansu" uniqKey="Birinci T" first="Tansu" last="Birinci">Tansu Birinci</name><affiliation><nlm:affiliation>4 Department of Physiotherapy and Rehabilitation, Istanbul University , Istanbul, Turkey .</nlm:affiliation></affiliation></author></analytic><series><title level="j">Lymphatic research and biology</title><idno type="eISSN">1557-8585</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Platelet-rich plasma (PRP) is an autologous concentrated preparation of human platelets contained in a small volume of plasma that is characterized by hemostatic and tissue-repairing effects. Being enriched by various kinds of growth factors, and their tissue-repairing effects have made them the focus of attention for use in tissue regeneration. PRP has been safely used and documented in many different fields, including orthopedics, sports injuries, dental and periodontal surgery, and cosmetic, plastic, cardiovascular, general, and maxillofacial surgery. The current evidence obtained from in vitro and animal studies pointed out that PRP may potentially be used to regenerate injured lymphatic vessels to treat or prevent lymphedema. Therefore, we have reviewed existing literature on the clinical uses of PRP in lymphedema and inquired whether there is enough evidence to support the use of PRP in clinical practice as a treatment option. In contrast to in vitro and animal models, there is no clinical trial regarding the use of PRP in lymphedema treatment. Only two animal studies matched to our research yielded positive and promising results in terms of the potential role of PRP in future for lymphedema therapies. In the light of these findings, it is clear that this is an important issue that should be studied in greater depth to clarify the efficacy of PRP in the management of lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27599222</PMID><DateCreated><Year>2016</Year><Month>09</Month><Day>06</Day></DateCreated><DateRevised><Year>2016</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8585</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Lymphatic research and biology</Title><ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation></Journal><ArticleTitle>Applications of Platelet-Rich Plasma in Lymphedema.</ArticleTitle><Pagination><MedlinePgn>206-209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2015.0060</ELocationID><Abstract><AbstractText>Platelet-rich plasma (PRP) is an autologous concentrated preparation of human platelets contained in a small volume of plasma that is characterized by hemostatic and tissue-repairing effects. Being enriched by various kinds of growth factors, and their tissue-repairing effects have made them the focus of attention for use in tissue regeneration. PRP has been safely used and documented in many different fields, including orthopedics, sports injuries, dental and periodontal surgery, and cosmetic, plastic, cardiovascular, general, and maxillofacial surgery. The current evidence obtained from in vitro and animal studies pointed out that PRP may potentially be used to regenerate injured lymphatic vessels to treat or prevent lymphedema. Therefore, we have reviewed existing literature on the clinical uses of PRP in lymphedema and inquired whether there is enough evidence to support the use of PRP in clinical practice as a treatment option. In contrast to in vitro and animal models, there is no clinical trial regarding the use of PRP in lymphedema treatment. Only two animal studies matched to our research yielded positive and promising results in terms of the potential role of PRP in future for lymphedema therapies. In the light of these findings, it is clear that this is an important issue that should be studied in greater depth to clarify the efficacy of PRP in the management of lymphedema.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akgül</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Gerontology, Faculty of Health Sciences, Istanbul University , Istanbul, Turkey .</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Department of Cardiovascular Surgery, Bakırköy Dr. Sadi Konuk Training and Research Hospital , Istanbul, Turkey .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirak</LastName><ForeName>Musa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3 Department of Neurosurgery, Bakırköy Dr. Sadi Konuk Training and Research Hospital , Istanbul, Turkey .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birinci</LastName><ForeName>Tansu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>4 Department of Physiotherapy and Rehabilitation, Istanbul University , Istanbul, Turkey .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lymphat Res Biol</MedlineTA><NlmUniqueID>101163587</NlmUniqueID><ISSNLinking>1539-6851</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27599222</ArticleId><ArticleId IdType="doi">10.1089/lrb.2015.0060</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000636 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000636 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27599222
|texte= Applications of Platelet-Rich Plasma in Lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27599222" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |